Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Shares Issued (2018 - 2025)

OptimizeRx's Shares Issued history spans 10 years, with the latest figure at $1000.0 for Q3 2023.

  • For Q3 2023, Shares Issued fell 99.54% year-over-year to $1000.0; the TTM value through Sep 2023 reached $169377.0, down 99.75%, while the annual FY2022 figure was $1.1 million, 98.48% down from the prior year.
  • Shares Issued for Q3 2023 was $1000.0 at OptimizeRx, down from $105000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $70.7 million in Q1 2021 and bottomed at -$68.0 million in Q2 2021.
  • The 5-year median for Shares Issued is $219630.0 (2022), against an average of $5.0 million.
  • The largest YoY upside for Shares Issued was 70571.54% in 2021 against a maximum downside of 251706611.11% in 2021.
  • A 5-year view of Shares Issued shows it stood at -$1.1 million in 2019, then surged by 208.46% to $1.2 million in 2020, then soared by 5682.69% to $66.9 million in 2021, then crashed by 99.97% to $23377.0 in 2022, then tumbled by 95.72% to $1000.0 in 2023.
  • Per Business Quant, the three most recent readings for OPRX's Shares Issued are $1000.0 (Q3 2023), $105000.0 (Q2 2023), and $40000.0 (Q1 2023).